Cite
Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
MLA
Zweck, Elric, et al. “Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.” Circulation, vol. 150, no. 25, Dec. 2024, pp. 1990–2003. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.124.072370.
APA
Zweck, E., Hassager, C., Beske, R. P., Jensen, L. O., Eiskjær, H., Mangner, N., Polzin, A., Schulze, P. C., Skurk, C., Nordbeck, P., Clemmensen, P., Panoulas, V., Zimmer, S., Schäfer, A., Kelm, M., Engstrøm, T., Holmvang, L., Junker, A., Schmidt, H., … Møller, J. E. (2024). Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial. Circulation, 150(25), 1990–2003. https://doi.org/10.1161/CIRCULATIONAHA.124.072370
Chicago
Zweck, Elric, Christian Hassager, Rasmus P Beske, Lisette O Jensen, Hans Eiskjær, Norman Mangner, Amin Polzin, et al. 2024. “Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.” Circulation 150 (25): 1990–2003. doi:10.1161/CIRCULATIONAHA.124.072370.